Following on from the first parter, Lawsuit Alleges GSK's Witty Lied to the Media - Part I, today sees part 2 (The claims of ChinaWhys against GSK) - Part 3 (Coming later this week) will focus on the incarceration of Peter Humphrey and his wife, Yu Yinzeng and also the rehiring of accused whistleblower, Vivian Shi)
Here is what Peter Humphrey and his wife, Yu Yinzeng, of ChinaWhys, are alleging...
- Between 2010-2013 GSK spent nearly $225 million on planning and travel services. Approx 44% of the sampled invoices were inflated and approximately 12% were for events that did not occur.
- GSK set up a special "crisis management" team in order to bribe Chinese regulators with money and gifts. A GSK executive attempted to bribe a Chinese investigator with an IPad and a lavish dinner. All bribes were approved by the head of Chinese operations, Mark Reilly.
- GSK planned to suppress evidence of its illegal bribery activities.
- As far back as 2008, GSK China deliberately falsified its books and records in order to conceal its illegal practices in China. These included, bribery and promotion of drugs for purposes that have not been approved by the Chinese authorities.
- GSK paid a patient RMB 50,000, who nearly died after being given Lamictal off-label. Despite having knowledge of Lamictal causing near death in this patient, GSK still told its reps to promote the use of Lamictal for off-label purposes.
- GSK targeted 'persuasive doctors' in attempts to influence purchasing decisions at their hospitals. GSK are to said to have forged a connection with these doctors by taking them to expensive lunches and dinners and also giving them gifts and cash.
- GSK paid between 500 and 1,000 doctors to go on an all-expenses paid holiday to locations such as Brazil, India, Israel, Greece, Japan and Hungary. GSK covered all costs, including cash to cover meals and sight-seeing excursions. These were disguised by GSK as "Conference trips."
- Head of Chinese operations, Mark Reilly, received a bribe in the form of 'sexual relations' in return for passing business on to China Comfort Travel, a travel agency who organised 'conference sevices' for GSK.
- GSK paid doctors based on their prescription numbers.
- GSK's senior legal counsel, Jennifer Huang, asked private investigator, Peter Humphrey, to investigate the Public Security Bureau and to prepare an analysis of the Chinese political regime. Huang told Humphrey that she wanted to find out who's who regarding the team who were investigating GSK.
- Humphrey became concerned that GSK were trying to obstruct the investigation and declined to investigate state secrets.
- Humphrey was also asked, by GSK, to look into the Ministry of Public Security, the Economic Crimes Investigation Department regarding the relationship between them and the Public Security Bureau. Humphrey, once again, declined.
- Head of Chinese operations, Mark Reilly, told Humphrey that the alleged whistleblower, Vivian Shi was "coming after him." (Humphrey). Reilly then fled China the following day.
- GSK China told its employees to "destroy all non-compliant promotional materials and gifts." They also implemented a new email system and deleted emails that were more than a year old. They claimed this was to "reduce unnecessarily legal costs."
--
Bob Fiddaman.
Back Stories from the Fiddaman Blog
Glaxo - The Sex Tape Scandal
GSK's Mark Reilly Accused of Running a "massive bribery network"
I'm Just a Blogger - Here's GSK Served on Prawn Crackers
GSK Hiked Product Prices to Fund Bribery Scam
GSK's Sales Reps Want Their Money Back
GSK's Private Investigator [The Video]
Peter Humphrey's 2012 Presentation - Pharma Bribery
GSK's Chinese Whispers and David Cameron
“GSK were really cagey", Claims Whitehall Official.
Glaxo Hire Ropes & Gray to Delve Into its Chinese Operations.
GSK CHINA - Bribery was Rife 13 Years Ago
Witty Plays Down China Scandal
Witty Witty Bang Wang. The Glaxo Gangbang...Allegedly
Book Your Holidays With GSK Travel
Andrew Witty... I know narrrrrrrrthing
The Penny Drops for GSK's Private Investigator.
GSK China Bought Patient’s Silence for $9,000
Lawsuit Alleges GSK's Witty Lied to the Media - Part I
No comments: